Dr. Paul S. Mischel's lab at Stanford University focuses on developing new treatments for glioblastoma, a highly aggressive brain cancer. The research aims to discover the proteins that glioblastoma cells depend on for survival, particularly when they have a mutated form of the epidermal growth factor receptor (EGFR). By using advanced chemical and proteomic techniques, the lab seeks to identify drug targets that can lead to more effective therapies for this challenging disease.

Dr. Lauren O'Connell's lab studies how young animals learn to communicate and interact with others through movement, a process known as perceptual motor development. Using social tadpoles, her research explores how dopamine signaling and a specific protein related to Fragile X syndrome affect this development. By understanding these brain mechanisms, the lab aims to uncover insights that could help in addressing communication and developmental issues, particularly in conditions like autism.

Dr. Seung K. Kim's lab focuses on understanding pancreatic cancer and its relationships with diabetes. They investigate how certain cells in the pancreas undergo changes that could lead to cancer, particularly pancreatic ductal adenocarcinoma (PDAC). The lab studies interactions between immune cells and cancer cells to determine how these relationships influence disease development. They aim to uncover the genetic and signaling pathways involved in these processes to help improve treatment options and early diagnosis.

Dr. Dmitri Petrov's research lab at Stanford University focuses on understanding how organisms adapt rapidly to changing environments. By studying various experimental systems, such as yeast and fruit flies, along with cancer models in mice, the lab aims to build a comprehensive theory of adaptation that accounts for both short-term evolution and patterns seen in long-term genomic data.

In Jeffrey D. Axelrod's lab at Stanford University, researchers focus on understanding planar cell polarity (PCP) signaling, a critical process that ensures cells are correctly oriented and positioned within tissues. This signaling pathway is important for proper heart development and can lead to congenital heart defects when disrupted. The lab employs the fruit fly Drosophila as a model organism, using advanced genetic, imaging, and biochemical techniques to uncover the mechanisms behind PCP signaling. Their work not only advances basic biology but also aims to inform potential treatments for related diseases.

Dr. Or P. Gozani's lab at Stanford University studies how protein methylation affects cell biology and contributes to diseases. They focus on modifications that happen on proteins, especially those related to chromatin and gene expression. This research aims to uncover the roles of specific enzymes involved in these processes, which may lead to new treatments for various health issues.

Joseph D Puglisi's lab at Stanford University focuses on understanding how protein translation works, especially in relation to neurodegenerative diseases like Alzheimer's and ALS. They look into an unusual form of translation called RAN translation, which can lead to the production of harmful proteins when certain genetic sequences are repeated too many times. By combining techniques from biophysics and genetics, the lab aims to uncover how translation mechanisms can go awry and what can be done to mitigate their effects on health.

The Roth lab at Stanford University focuses on engineering human cells for therapeutic applications, particularly in cancer treatment. They aim to create new cell states that can enhance the function of primary human T cells using advanced genetic modifications. By leveraging cutting-edge technologies such as CRISPR, the lab explores how to produce new non-evolved human genes to optimize immune responses against tumors.

Dr. Ansuman Satpathy's lab at Stanford University focuses on creating detailed maps of genetic regulatory elements in human immune cells. By using advanced single-cell technology, the lab studies how these elements behave during different life stages and across various diseases, including cancer and autoimmune conditions. Their work aims to improve our understanding of how genetic differences can affect health and disease.

Dr. Jan M. Skotheim's lab at Stanford University focuses on understanding how cells control their growth and division, with a particular emphasis on budding yeast as a model system. The lab aims to uncover the molecular mechanisms that link cell growth to cell division, and how these processes are disrupted in cancer. Their research has significant implications for both basic biology and medical applications, especially in developing new cancer treatments.

Dr. Margaret T. Fuller's lab at Stanford University studies how adult stem cells transition from proliferating to differentiating. Their research focuses on understanding the cellular mechanisms that govern this critical switch, which is important for the proper development of cells in various tissues. They use Drosophila sperm development as a model to uncover these processes, aiming to gain insights that could advance knowledge about tissue maintenance and cancer prevention.

Dr. Inma Cobos' research lab at Stanford focuses on understanding how different brain cells respond to Alzheimer's disease. By studying humanized mouse models, the lab aims to identify which types of brain cells are especially vulnerable to the disease and how they interact with each other. Their work will help uncover the mechanisms that lead to cognitive deficits and advance the understanding of Alzheimer's pathology.

Dr. Gerald R. Crabtree's lab focuses on developing innovative small molecules to treat blood cancers, specifically Diffuse Large B Cell Lymphoma (DLBCL). They employ a unique strategy to trick cancer cells into activating their own cell death mechanisms using engineered compounds that target specific genes involved in cancer growth. This research could lead to more precise and effective cancer therapies with fewer side effects.

Dr. Martha S. Cyert's lab at Stanford University focuses on understanding how calcineurin, a crucial protein involved in calcium signaling, works at cellular membranes. The research explores how calcineurin interacts with proteins through a process called S-acylation, which involves the addition of fatty acids to proteins. This work has implications for diseases such as cancer and immune disorders, as well as a better understanding of cellular processes and potential therapeutic targets.

Dr. Jeanne Shen's lab focuses on improving treatment outcomes for colorectal cancer using advanced machine learning techniques. They are creating sophisticated models that analyze a combination of medical imaging, pathology slides, and clinical records to better predict patient risk and treatment effectiveness. The research aims to make these tools publicly available to help other researchers and clinicians enhance cancer care more broadly.

Dr. Robert B. West's lab at Stanford University focuses on breast cancer research, particularly the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer (IBC). The lab studies how certain immune cells, particularly macrophages, behave in the tumor microenvironment to identify new biomarkers that could predict cancer progression. Their research aims to improve our understanding of cancer biology and to better predict patient outcomes based on specific tumor characteristics.

Dr. William S Talbot's lab at Stanford University studies glial cells in the central nervous system, particularly focusing on oligodendrocytes and microglia. Using zebrafish as a model organism, the lab investigates how these cells develop, function, and respond to various signals. The ultimate aim is to understand the genetic mechanisms underlying brain health and disease, which could lead to new treatments for neurological disorders.

Dr. Michael R. Howitt's lab at Stanford University focuses on understanding unique cells in the colon called tuft cells, which play a critical role in sensing infections and regulating the immune response. By studying how these cells interact with the gut microbiome, especially under the influence of different organisms, the research aims to develop insights for treating gastrointestinal disorders. The lab's work may lead to new therapies for infections and inflammation in the gut.

Dr. Bali Pulendran's lab at Stanford University focuses on understanding how vaccines work, particularly in relation to COVID-19 and malaria. They use advanced techniques to investigate the immune responses induced by vaccines, taking into account factors like the microbiome and individual variations. The lab aims to identify signature patterns in immune responses that can predict how well different populations respond to vaccination, especially in children and those with specific health conditions.

Dr. Anne M Villeneuve's lab focuses on how chromosomes are accurately divided during the process of meiosis, which is essential for producing healthy eggs and sperm. By studying a small roundworm called Caenorhabditis elegans, the lab aims to uncover the important molecular and cellular processes that ensure chromosomes are inherited correctly. This research is crucial because mistakes in chromosome segregation can lead to miscarriages, birth defects, and even cancer.